Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19253325 | YEAST STAGE TANK INCORPORATED FERMENTATION SYSTEM AND METHOD | June 2025 | February 2026 | Allow | 8 | 1 | 1 | No | No |
| 18821389 | YEAST STAGE TANK INCORPORATED FERMENTATION SYSTEM AND METHOD | August 2024 | March 2025 | Allow | 6 | 1 | 0 | No | No |
| 18730185 | BACILLUS VELEZENSIS AND USE THEREOF | July 2024 | March 2026 | Allow | 20 | 2 | 1 | Yes | No |
| 18634887 | PRODUCTS AND METHODS USING LUNASIN-ENRICHED SOY EXTRACT MIXTURES TO REDUCE FREE FATTY ACID LEVELS, INCREASE LEPTIN LEVELS AND INCREASE ADIPONECTIN LEVELS IN PLASMA | April 2024 | February 2025 | Allow | 10 | 0 | 0 | No | No |
| 18601669 | ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION | March 2024 | September 2025 | Abandon | 18 | 1 | 1 | No | No |
| 18443753 | METHOD OF PURIFYING A PROTEIN FROM FERMENTATION SOLIDS UNDER DESORBING CONDITIONS | February 2024 | November 2025 | Allow | 21 | 2 | 1 | No | No |
| 18418062 | METHODS FOR QUANTIFYING MIXED-LINKAGE BETA GLUCAN | January 2024 | November 2025 | Allow | 21 | 2 | 1 | Yes | No |
| 18391226 | Tank mix adjuvant system for spore forming and nonspore forming bacteria for residue breakdown | December 2023 | August 2025 | Abandon | 20 | 3 | 1 | No | No |
| 18386637 | PROCESSES FOR CO-PRODUCING XYLITOL WITH ETHANOL OR OTHER FERMENTATION PRODUCTS | November 2023 | March 2025 | Abandon | 17 | 2 | 0 | No | No |
| 18489816 | COCAINE ESTERASE MUTANT AND USE THEREOF | October 2023 | October 2024 | Allow | 12 | 2 | 1 | No | No |
| 18471658 | Bacillus Strains Improving Health and Performance of Production Animals | September 2023 | March 2025 | Allow | 18 | 2 | 1 | Yes | No |
| 18213687 | USING AUTOLOGOUS MESENCHYMAL STEM CELLS TO TREAT MULTIPLE SYSTEM ATROPHY | June 2023 | July 2024 | Allow | 12 | 1 | 0 | No | No |
| 18205980 | LOW OXYGEN CULTURE CONDITIONS FOR MAINTAINING RETINAL PROGENITOR CELL MULTIPOTENCY | June 2023 | October 2024 | Abandon | 16 | 1 | 1 | No | No |
| 18315774 | FEED CONTROL IN CONVERSION OF BIOMASS INTO HYDROCARBON FUELS AND CHEMICALS | May 2023 | March 2025 | Allow | 23 | 2 | 1 | Yes | No |
| 18143361 | YEAST STAGE TANK INCORPORATED FERMENTATION SYSTEM AND METHOD | May 2023 | April 2024 | Allow | 12 | 1 | 1 | No | No |
| 18141821 | PAIRING PROBIOTICS AND PREBIOTICS, METHODS FOR GROWTH AND USE, SEPARATELY AND IN COMBINATION | May 2023 | April 2024 | Allow | 11 | 1 | 1 | Yes | No |
| 18122009 | PREPARATION METHOD AND APPLICATION OF DECELLULARIZED EXTRACELLULAR MATRIX TISSUE PAPER | March 2023 | November 2024 | Allow | 20 | 2 | 1 | Yes | No |
| 18166348 | METHOD FOR PRODUCING RENEWABLE FUELS | February 2023 | June 2024 | Allow | 16 | 1 | 1 | No | No |
| 18161008 | ASPERGILLUS TERREUS STRAIN AND COMPOSITION FOR CONTROLLING BACTERIAL PLANT DISEASES USING STRAIN OR CULTURE FILTRATE THEREOF | January 2023 | July 2025 | Allow | 30 | 2 | 1 | Yes | No |
| 18100000 | SCAFFOLDS FABRICATED FROM ELECTROSPUN DECELLULARIZED EXTRACELLULAR MATRIX | January 2023 | August 2024 | Allow | 19 | 2 | 1 | No | No |
| 18155504 | MICROBIAL COMPOSITIONS AND METHODS | January 2023 | November 2024 | Allow | 22 | 4 | 1 | Yes | No |
| 17979123 | PROCESSES FOR CO-PRODUCING XYLITOL WITH ETHANOL OR OTHER FERMENTATION PRODUCTS | November 2022 | November 2023 | Abandon | 12 | 1 | 1 | No | No |
| 17966579 | SYSTEMS, METHODS, AND APPARATUS FOR INCREASING BIOREACTOR CAPACITY USING SILICA POLYMERS | October 2022 | May 2024 | Abandon | 20 | 0 | 1 | No | No |
| 17916106 | COMPOSITIONS AND METHODS FOR CONTROLLING FUNGAL DISEASES IN PLANTS | September 2022 | March 2025 | Abandon | 30 | 0 | 1 | No | No |
| 17938958 | METHOD OF TREATING PANCREAS DAMAGE | September 2022 | March 2026 | Abandon | 42 | 1 | 1 | No | No |
| 17905450 | COMPOSITION FOR REGULATING STEM CELL FUNCTION COMPRISING THE GENUS LACTOBACILLUS BACTERIA-DERIVED EXTRACELLULAR VESICLES (EVS) AS AN ACTIVE INGREDIENT | September 2022 | November 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17905147 | BIOMATERIALS AND RELATED METHODS AND KITS | August 2022 | November 2025 | Abandon | 39 | 0 | 1 | No | No |
| 17886730 | USING AUTOLOGOUS MESENCHYMAL STEM CELLS TO TREAT MULTIPLE SYSTEM ATROPHY | August 2022 | March 2023 | Allow | 7 | 1 | 0 | No | No |
| 17869433 | Composition Comprising Lactobacillus Plantarum 2830 (ECGC 13110402) | July 2022 | November 2023 | Allow | 16 | 1 | 1 | Yes | No |
| 17862614 | YEAST STAGE TANK INCORPORATED FERMENTATION SYSTEM AND METHOD | July 2022 | February 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 17853570 | METHODS AND AGRICULTURAL COMPOSITIONS FOR PREVENTING OR CONTROLLING PLANT DISEASES | June 2022 | April 2024 | Abandon | 21 | 1 | 1 | No | No |
| 17847827 | DEVICE FOR LIQUID PROCESSING IN CELL CULTURE PROCESS | June 2022 | November 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17837735 | HORSESHOE CRAB-DERIVED RECOMBINANT FACTOR G AND METHOD OF MEASURING B-GLUCAN USING SAME | June 2022 | October 2025 | Allow | 40 | 1 | 1 | No | No |
| 17828266 | CAMELLIA SINENSIS ENDOPHYTE PENICILLIUM EHRLICHII AND APPLICATION THEREOF | May 2022 | January 2024 | Abandon | 19 | 2 | 1 | No | No |
| 17828325 | Purification of Reptilian Hyaluronic Acid and Its Use for Soft and Hard Tissue Repair and Regeneration | May 2022 | October 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17779169 | BACILLUS THURINGIENSIS PESTICIDE FORMULATIONS | May 2022 | September 2025 | Abandon | 39 | 4 | 0 | No | No |
| 17744222 | USE OF PENICILLIUM EHRLICHII IN CONTROLLING PLANT PESTS, AND A CONTROL METHOD | May 2022 | June 2024 | Abandon | 25 | 2 | 0 | No | No |
| 17742123 | CELL PRESERVATION OR TRANSPORTATION INSTRUMENT AND CELL TRANSPORATION METHOD | May 2022 | January 2026 | Allow | 45 | 1 | 1 | No | No |
| 17732015 | Novel Pain relief Composition and Method of Use | April 2022 | March 2025 | Allow | 34 | 1 | 1 | Yes | No |
| 17725377 | COMPOSITIONS AND METHODS FOR TREATMENT OF CONDITIONS USING FRACTIONATED HONEY | April 2022 | August 2025 | Allow | 39 | 2 | 1 | Yes | No |
| 17721690 | METHODS OF MAKING RED BLOOD CELLS AND PLATELETS IN VITRO AND USES THEREOF | April 2022 | August 2024 | Allow | 28 | 2 | 1 | No | No |
| 17655731 | ENZYME COMPOSITIONS WITH REDUCED VIRAL AND MICROBIAL CONTAMINATION | March 2022 | December 2023 | Allow | 21 | 2 | 0 | No | No |
| 17699765 | METHOD OF PREPARING AN OSTEOGENIC BONE GRAFT | March 2022 | September 2024 | Allow | 30 | 2 | 1 | Yes | No |
| 17696381 | Composition and method for breaking down crop residue and adding nutrients to soil | March 2022 | June 2025 | Allow | 39 | 10 | 1 | Yes | Yes |
| 17694588 | CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS | March 2022 | May 2023 | Abandon | 14 | 1 | 0 | No | No |
| 17686783 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | March 2022 | October 2023 | Allow | 20 | 2 | 1 | Yes | No |
| 17680830 | PAIRING PROBIOTICS AND PREBIOTICS, METHODS FOR GROWTH AND USE, SEPARATELY AND IN COMBINATION | February 2022 | March 2023 | Allow | 13 | 1 | 0 | Yes | No |
| 17638152 | NOVEL TEMPERATURE-OPTMIZED BACILLI | February 2022 | December 2025 | Allow | 45 | 2 | 1 | No | No |
| 17635867 | CELL CULTURE ASSEMBLIES AND METHODS OF USING THE SAME | February 2022 | August 2025 | Abandon | 42 | 0 | 1 | No | No |
| 17666449 | Microbial compositions for use with plants for the prevention or reduction of fungal pathogens | February 2022 | December 2023 | Abandon | 23 | 1 | 1 | No | No |
| 17581469 | SYSTEM, METHOD AND INTERFACE FOR PARALLEL PROCESSING OF ANTIMICROBIAL SUSCEPTIBILITY TESTS USING DIFFERENT SAMPLES | January 2022 | January 2025 | Abandon | 36 | 4 | 1 | Yes | No |
| 17628710 | METHOD FOR MASS PROLIFERATION OF STEM CELLS WITHOUT USING HYDROGEL | January 2022 | December 2025 | Allow | 46 | 1 | 1 | Yes | No |
| 17565169 | METHOD FOR ANAEROBICALLY FERMENTING ORGANIC SOLID WASTE | December 2021 | April 2022 | Allow | 3 | 0 | 0 | Yes | No |
| 17546447 | THROMBIN SOLUTION AND METHODS OF USE THEREOF | December 2021 | January 2024 | Allow | 25 | 3 | 0 | No | No |
| 17539848 | COMPOSITION AND METHOD FOR TREATING EQUINE SARCOIDS | December 2021 | April 2024 | Abandon | 28 | 1 | 0 | No | No |
| 17613993 | XENO-FREE AND TRANSGENE-FREE REPROGRAMING OF MESENCHYMAL STEM CELLS TOWARD NEURAL PROGENITOR CELLS | November 2021 | November 2025 | Allow | 47 | 2 | 1 | No | No |
| 17533771 | METHODS FOR PRODUCING BIOMASS RICH IN DHA, PALMITIC ACID AND PROTEIN USING A EUKARYOTIC MICROORGANISM | November 2021 | June 2024 | Allow | 31 | 3 | 0 | Yes | No |
| 17530267 | Liposomal Delivery System for Beauveria bassiana Strain GHA spores to bed bugs. | November 2021 | March 2025 | Abandon | 40 | 1 | 1 | No | No |
| 17529474 | METHOD FOR PREVENTING OR ALLEVIATING PARTICULATE MATTER-INDUCED LUNG INJURY | November 2021 | June 2024 | Allow | 31 | 3 | 0 | No | No |
| 17595493 | METHODS OF GENERATING AND EXPANDING HEMATOPOIETIC STEM CELLS | November 2021 | September 2025 | Allow | 46 | 1 | 1 | Yes | No |
| 17525915 | METHODS OF PEST CONTROL | November 2021 | July 2023 | Allow | 20 | 2 | 1 | Yes | No |
| 17611064 | A HUMAN IN VITRO CARDIOTOXICITY MODEL | November 2021 | June 2025 | Allow | 43 | 1 | 1 | Yes | No |
| 17610421 | HIGH YIELD LACTIC ACID PRODUCTION USING MIXED CULTURES | November 2021 | May 2022 | Allow | 6 | 0 | 0 | Yes | No |
| 17610116 | MITOCHONDRIAL RESPIROMETRY IN FROZEN SPECIMENS | November 2021 | September 2024 | Abandon | 35 | 0 | 1 | No | No |
| 17609687 | A METHOD TO MANUFACTURE A COMPOSITION COMPRISING PLATELET-RICH PLASMA, AN APPARATUS FOR CENTRIFUGATION AND A KIT UTILISABLE FOR ACTUATING THE METHOD, THE COMPOSITION, AND USE OF THE COMPOSITION | November 2021 | March 2025 | Abandon | 40 | 0 | 1 | No | No |
| 17520325 | PAIRING PROBIOTICS AND PREBIOTICS, METHODS FOR GROWTH AND USE, SEPARATELY AND IN COMBINATION | November 2021 | March 2023 | Allow | 17 | 1 | 0 | Yes | No |
| 17604882 | Broad Spectrum Biopesticides Comprising Beneficial Microorganisms | October 2021 | January 2025 | Abandon | 39 | 1 | 1 | No | No |
| 17503962 | SULFITE-BASED PROCESSES FOR PRODUCING NANOCELLULOSE, AND COMPOSITIONS AND PRODUCTS PRODUCED THEREFROM | October 2021 | August 2024 | Allow | 33 | 4 | 0 | No | No |
| 17500606 | Bacillus Strains Improving Health and Performance of Production Animals | October 2021 | June 2023 | Allow | 20 | 1 | 1 | No | No |
| 17498014 | PROCESSES FOR PRODUCING LIGNIN-COATED HYDROPHOBIC CELLULOSE, AND COMPOSITIONS AND PRODUCTS PRODUCED THEREFROM | October 2021 | June 2023 | Allow | 20 | 1 | 0 | No | No |
| 17449699 | PROBIOTIC COMPOSITION INCLUDING LACTIC ACID BACTERIAL STRAINS AND USE OF AT LEAST ONE OF SUCH STRAINS | October 2021 | April 2024 | Allow | 30 | 3 | 0 | Yes | No |
| 17487833 | PRODUCING METHOD FOR PLURIPOTENT STEM CELL CAPABLE OF DIFFERENTIATING INTO SPECIFIC CELL AND APPLICATION THEREOF | September 2021 | February 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17406761 | BIOLOGICAL-BASED CATALYST TO DELAY PLANT DEVELOPMENT PROCESSES | August 2021 | November 2025 | Abandon | 51 | 3 | 1 | Yes | No |
| 17395459 | METHODS OF OIL PRODUCTION IN MICROORGANISMS | August 2021 | June 2022 | Allow | 10 | 2 | 0 | No | No |
| 17394695 | DEVICE FOR FERMENTATION INTEGRATED WITH SEPARATION AND PURIFICATION OF ALCOHOLS | August 2021 | March 2025 | Abandon | 44 | 4 | 0 | No | No |
| 17426869 | BIODEGRADABLE SCAFFOLD FOR HAIR GROWTH AND METHODS OF USE THEREFOR | July 2021 | November 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17378174 | METHOD FOR DETERMINING WHETHER OR NOT TEST SAMPLE CONTAINS PHYTOPATHOGENIC FUNGUS | July 2021 | March 2023 | Allow | 20 | 1 | 0 | No | No |
| 17369855 | PRODUCTS AND METHODS USING LUNASIN-ENRICHED SOY EXTRACT MIXTURES TO REDUCE FREE FATTY ACID LEVELS, INCREASE LEPTIN LEVELS AND INCREASE ADIPONECTIN LEVELS IN PLASMA | July 2021 | January 2024 | Allow | 30 | 1 | 0 | No | No |
| 17354801 | Scalable Production of Standardized Extracellular Vesicles, Extracellular Vesicle Preparations and Uses Thereof | June 2021 | June 2023 | Abandon | 24 | 1 | 1 | No | No |
| 17299643 | PROCESS AND APPARATUS FOR PRODUCING EXOSOMES | June 2021 | September 2024 | Abandon | 40 | 0 | 1 | No | No |
| 17335558 | MATERIALS AND METHODS FOR MODULATING GLUCOSE UPTAKE | June 2021 | October 2025 | Abandon | 53 | 4 | 1 | No | No |
| 17297481 | USE OF PENICILLIUM SCLEROTIORUM IN PREPARATION OF PLANT GROWTH REGULATOR OR INDUCER | May 2021 | March 2025 | Abandon | 45 | 1 | 1 | No | No |
| 17295385 | PRODUCING METHOD OF MESENCHYMAL STEM CELL FOR PREVENTION OR TREATMENT OF BRAIN NEURONAL DISEASE INCLUDING GHRELIN TREATMENT AND USE THEREOF | May 2021 | June 2025 | Allow | 49 | 2 | 1 | No | No |
| 17235952 | ANTI-THROMBOTIC AND ENDOTHELIALIZATION-ENHANCED BIOPROSTHETIC VALVE MATERIAL AND PREPARATION METHOD THEREOF | April 2021 | March 2025 | Allow | 46 | 2 | 1 | Yes | No |
| 17233133 | METHODS FOR RAPID ANTIMICROBIAL SUSCEPTIBILITY TESTING | April 2021 | May 2025 | Abandon | 49 | 4 | 1 | Yes | Yes |
| 17285247 | MULTIPLE-FUNCTION BIOLOGICAL COMPOSITION | April 2021 | April 2024 | Allow | 36 | 3 | 1 | No | No |
| 17226492 | VACUUM-ASSISTED PLASMA SEPARATION | April 2021 | September 2025 | Allow | 54 | 5 | 1 | No | No |
| 17226464 | VACUUM-ASSISTED PLASMA SEPARATION | April 2021 | April 2022 | Allow | 12 | 0 | 0 | Yes | No |
| 17222217 | METHOD FOR PRODUCING RENEWABLE FUELS | April 2021 | September 2023 | Allow | 29 | 2 | 1 | No | No |
| 17204233 | Brain Function Improving Agent | March 2021 | March 2025 | Abandon | 48 | 4 | 1 | Yes | No |
| 17198895 | DECELLULARIZED EXTRACELLULAR MATRIX, PREPARATION PROCESS AND USES THEREOF | March 2021 | August 2024 | Allow | 41 | 4 | 1 | No | No |
| 17196327 | EXOSOME EXTRACTION DEVICE AND EXOSOME EXTRACTION METHOD | March 2021 | August 2024 | Allow | 41 | 2 | 1 | No | No |
| 17193562 | METHOD OF CULTURING AKKERMANSIA | March 2021 | August 2023 | Abandon | 30 | 2 | 1 | No | No |
| 17192334 | PESTICIDAL FLAVOBACTERIUM STRAIN AND BIOACTIVE COMPOSITIONS METABOLITES AND USES | March 2021 | December 2022 | Abandon | 22 | 1 | 1 | No | No |
| 17171885 | Cell Expansion Methods and Therapeutic Compositions | February 2021 | November 2023 | Abandon | 33 | 2 | 1 | No | No |
| 17266489 | ENDOPHYTIC MICROBES FOR GROWTH PROMOTION OF CROP PLANTS AND SUPPRESSION OF AGGRESSIVE INVASIVE PLANT SPECIES | February 2021 | August 2025 | Allow | 54 | 5 | 1 | Yes | No |
| 17163947 | Targeting the renin-angiotensin system for treatment of environment-and pathogen-induced lung injury | February 2021 | February 2025 | Abandon | 48 | 4 | 1 | No | No |
| 17154147 | HUMAN ADIPOSE TISSUE WHITE AND `BROWN-ON-WHITE` PROGENITORS FOR RECONSTRUCTIVE AND METABOLIC THERAPIES | January 2021 | November 2022 | Abandon | 22 | 1 | 1 | No | No |
| 17262054 | METHOD AND APPARATUS FOR SELF-CULTURING AUTOLOGOUS STEM CELLS | January 2021 | March 2026 | Abandon | 60 | 2 | 1 | No | No |
| 17258292 | All-in-One Distributed and Portable Fermentation Systems with Platform for Holding Same | January 2021 | May 2024 | Abandon | 40 | 0 | 1 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner TICHY, JENNIFER M.H..
With a 75.0% reversal rate, the PTAB has reversed the examiner's rejections more often than affirming them. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 40.6% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
✓ Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.
Examiner TICHY, JENNIFER M.H. works in Art Unit 1653 and has examined 617 patent applications in our dataset. With an allowance rate of 62.7%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 32 months.
Examiner TICHY, JENNIFER M.H.'s allowance rate of 62.7% places them in the 23% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by TICHY, JENNIFER M.H. receive 2.30 office actions before reaching final disposition. This places the examiner in the 65% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by TICHY, JENNIFER M.H. is 32 months. This places the examiner in the 49% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +38.3% benefit to allowance rate for applications examined by TICHY, JENNIFER M.H.. This interview benefit is in the 86% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 24.1% of applications are subsequently allowed. This success rate is in the 35% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 33.5% of cases where such amendments are filed. This entry rate is in the 50% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 57.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 48% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 84.0% of appeals filed. This is in the 78% percentile among all examiners. Of these withdrawals, 61.9% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.
When applicants file petitions regarding this examiner's actions, 68.0% are granted (fully or in part). This grant rate is in the 75% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.3% of allowed cases (in the 56% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.